These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2764510)
1. Modulation of prolactin receptors (PRL-R) by lactogenic and steroid hormones in human breast cancer cells in long-term tissue culture (T-47D). Leroy-Martin B; Peyrat JP Anticancer Res; 1989; 9(3):631-6. PubMed ID: 2764510 [TBL] [Abstract][Full Text] [Related]
2. Alteration of cell shape, adhesion, and lipid accumulation in human breast cancer cells (T-47D) by human prolactin and growth hormone. Shiu RP; Paterson JA Cancer Res; 1984 Mar; 44(3):1178-86. PubMed ID: 6692402 [TBL] [Abstract][Full Text] [Related]
3. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration. Murphy LJ; Murphy LC; Vrhovsek E; Sutherland RL; Lazarus L Cancer Res; 1984 May; 44(5):1963-8. PubMed ID: 6324992 [TBL] [Abstract][Full Text] [Related]
4. Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells. Reddel RR; Alexander IE; Koga M; Shine J; Sutherland RL Cancer Res; 1988 Aug; 48(15):4340-7. PubMed ID: 3390830 [TBL] [Abstract][Full Text] [Related]
5. Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture. Biswas R; Vonderhaar BK Cancer Res; 1987 Jul; 47(13):3509-14. PubMed ID: 3581086 [TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor gene expression in human breast cancer cells: regulation of expression by progestins. Murphy LC; Murphy LJ; Dubik D; Bell GI; Shiu RP Cancer Res; 1988 Aug; 48(16):4555-60. PubMed ID: 3260816 [TBL] [Abstract][Full Text] [Related]
7. Prolactin release-inhibitory effects of progesterone, megestrol acetate, and mifepristone (RU 38486) by cultured rat pituitary tumor cells. Lamberts SW; van Koetsveld P; Verleun T Cancer Res; 1987 Jul; 47(14):3667-71. PubMed ID: 3594432 [TBL] [Abstract][Full Text] [Related]
8. Prolactin (PRL) receptor induction in cultured rat hepatocytes: dual regulation by PRL and growth hormone. Barash I; Cromlish W; Posner BI Endocrinology; 1988 Mar; 122(3):1151-8. PubMed ID: 3342748 [TBL] [Abstract][Full Text] [Related]
9. Characterization of prolactin receptors and their distribution among American and Israeli women with breast cancer: implications for prediction of hormonal dependency and treatment. Ben-David M; Kadar T; Wittliff J; Biran S; Schally A Biomed Pharmacother; 1988; 42(2):101-9. PubMed ID: 3167163 [TBL] [Abstract][Full Text] [Related]
10. Required presence of both estrogen and pituitary factors for the growth of human breast cancer cells in athymic nude mice. Leung CK; Shiu RP Cancer Res; 1981 Feb; 41(2):546-51. PubMed ID: 7448802 [TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies. Elashry-Stowers D; Zava DT; Speers WC; Edwards DP Cancer Res; 1988 Nov; 48(22):6462-74. PubMed ID: 3180062 [TBL] [Abstract][Full Text] [Related]
12. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells. Koga M; Eisman JA; Sutherland RL Cancer Res; 1988 May; 48(10):2734-9. PubMed ID: 2834048 [TBL] [Abstract][Full Text] [Related]
13. Evidence for a novel pituitary factor that potentiates the mitogenic effect of estrogen in human breast cancer cells. Dembinski TC; Leung CK; Shiu RP Cancer Res; 1985 Jul; 45(7):3083-9. PubMed ID: 4005846 [TBL] [Abstract][Full Text] [Related]
14. Prolactin receptors in human breast cancer cells in long-term tissue culture. Shiu RP Cancer Res; 1979 Nov; 39(11):4381-6. PubMed ID: 227585 [TBL] [Abstract][Full Text] [Related]
15. Lack of relationship between the levels of prolactin receptors and steroid receptors in women with breast cancer. Ben-David M; Wittliff JL; Fekete M; Kadar T; Biran S; Schally AV Biomed Pharmacother; 1988; 42(5):327-34. PubMed ID: 3191209 [TBL] [Abstract][Full Text] [Related]
16. Modulation of lactogenic receptors by progestins in cultured human breast cancer cells. Murphy LJ; Murphy LC; Stead B; Sutherland RL; Lazarus L J Clin Endocrinol Metab; 1986 Feb; 62(2):280-7. PubMed ID: 3001123 [TBL] [Abstract][Full Text] [Related]
17. Effect of Org OD14 (LIVIAL) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cell lines. Chetrite GS; Kloosterboer HJ; Philippe JC; Pasqualini JR Anticancer Res; 1999; 19(1A):269-75. PubMed ID: 10226553 [TBL] [Abstract][Full Text] [Related]
18. Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer. Ormandy CJ; Hall RE; Manning DL; Robertson JF; Blamey RW; Kelly PA; Nicholson RI; Sutherland RL J Clin Endocrinol Metab; 1997 Nov; 82(11):3692-9. PubMed ID: 9360527 [TBL] [Abstract][Full Text] [Related]
19. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival. Menendez JA; Oza BP; Colomer R; Lupu R Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863 [TBL] [Abstract][Full Text] [Related]
20. Effects of Org OD14 (Livial) and its metabolites on 17 beta-hydroxysteroid dehydrogenase activity in hormone-dependent MCF-7 and T-47D breast cancer cells. Chetrite GS; Kloosterboer HJ; Philippe JC; Pasqualini JR Anticancer Res; 1999; 19(1A):261-7. PubMed ID: 10226552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]